 | • レポートコード：QAF27340 • 出版社/出版日：QYResearch / 2021年5月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、133ページ • 納品方法：Eメール（即日納品） • 産業分類：医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界のニューロモデュレーションデバイス・植込型輸液ポンプ市場について種類別（脊髄刺激、脳深部刺激療法、仙骨神経刺激療法、迷走神経刺激療法、胃刺激療法、経頭蓋磁気刺激療法、経皮的電気刺激療法、その他）、用途別（パーキンソン病、てんかん、痛み、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・ニューロモデュレーションデバイス・植込型輸液ポンプ市場の概要 ・世界の主要地域別ニューロモデュレーションデバイス・植込型輸液ポンプ市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界のニューロモデュレーションデバイス・植込型輸液ポンプ市場規模2016-2021：種類別（脊髄刺激、脳深部刺激療法、仙骨神経刺激療法、迷走神経刺激療法、胃刺激療法、経頭蓋磁気刺激療法、経皮的電気刺激療法、その他） ・世界のニューロモデュレーションデバイス・植込型輸液ポンプ市場予測2012-2027：種類別（脊髄刺激、脳深部刺激療法、仙骨神経刺激療法、迷走神経刺激療法、胃刺激療法、経頭蓋磁気刺激療法、経皮的電気刺激療法、その他） ・世界のニューロモデュレーションデバイス・植込型輸液ポンプ市場規模2016-2021：用途別（パーキンソン病、てんかん、痛み、その他） ・世界のニューロモデュレーションデバイス・植込型輸液ポンプ市場予測2012-2027：用途別（パーキンソン病、てんかん、痛み、その他） ・ニューロモデュレーションデバイス・植込型輸液ポンプのアメリカ市場規模と予測2016-2021 ・ニューロモデュレーションデバイス・植込型輸液ポンプのヨーロッパ市場規模と予測2016-2021 ・ニューロモデュレーションデバイス・植込型輸液ポンプの中国市場規模と予測2016-2021 ・ニューロモデュレーションデバイス・植込型輸液ポンプの日本市場規模と予測2016-2021 ・ニューロモデュレーションデバイス・植込型輸液ポンプの東南アジア市場規模と予測2016-2021 ・ニューロモデュレーションデバイス・植込型輸液ポンプのインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Medtronic、Boston Scientific Corporation、Abbott、Synapse Biomedical、Nevro Corporation、Neuropace、Cyberonics、Autonomic Technologies、Avery Biomedical、Greatbatch Medical） ・ニューロモデュレーションデバイス・植込型輸液ポンプの製造コスト分析 ・販売チャネル、流通業者、顧客 ・ニューロモデュレーションデバイス・植込型輸液ポンプの市場動向・機会・課題 ・調査の結論 |
An implantable infusion pump (IIP) is intended to provide long-term continuous or intermittent drug infusion. Possible routes of administration include intravenous, intra-arterial, subcutaneous, intraperitoneal, intrathecal, epidural, and intraventricular. The IIP is surgically placed in a subcutaneous pocket under the infraclavicular fossa or in the abdominal wall, and a catheter is threaded into the desired position.
The production mainly distributed in two regions of USA: Puerto Rico (83%), Massachusetts (17%). Medtronic is the manufacturing giants in this field, taking about 83% of the USA production. Medtronic is the largest player with 83% production market, followed by Codman & Shurtleff (J&J) with 15% in 2015.
USA implantable infusion pumps consumption increased from 23.71 K units in 2011 to 28.69 K units in 2015, with an average growth rate of 3.85%. Cancer Treatment and chronic pain treatment are the major fields where implantable infusion pumps are frequently used. In 2015, 18.14 K units’ implantable infusion pumps were used to relieve the pain of Cancer, accounting for 66.6% of the USA total consumption. 26% of implantable infusion pumps were used for chronic pain treatment.
With fast technology development and strong demand, implantable infusion pumps price kept relatively stable and changed from 9964 USD/Unit in 2011 to 9456 USD/Unit in 2015.
It is expected that the USA implantable infusion pumps comsumption will be 35 K Units in 2021 and the production revenue will reach 311 million USD. At the same time, the price may gradually decline. This industry is easily affected by the technological innovation and the policy.
Market Analysis and Insights: Global Neuromodulation Devices and Implantable Infusion Pumps Market
The global Neuromodulation Devices and Implantable Infusion Pumps market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.
Global Neuromodulation Devices and Implantable Infusion Pumps Scope and Market Size
The global Neuromodulation Devices and Implantable Infusion Pumps market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Neuromodulation Devices and Implantable Infusion Pumps market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Spinal Cord Stimulation
Deep Brain Stimulation
Sacral Nerve Stimulation
Vagal Nerve Stimulation
Gastric Stimulation
Transcranial Magnetic Stimulation
Transcutaneous Electrical Stimulation
Other
Segment by Application
Parkinson’s Disease
Epilepsy
Pain
Other
The Neuromodulation Devices and Implantable Infusion Pumps market is analysed and market size information is provided by regions (countries). Segment by Application, the Neuromodulation Devices and Implantable Infusion Pumps market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Medtronic
Boston Scientific Corporation
Abbott
Synapse Biomedical
Nevro Corporation
Neuropace
Cyberonics
Autonomic Technologies
Avery Biomedical
Greatbatch Medical
1 Neuromodulation Devices and Implantable Infusion Pumps Market Overview
1.1 Neuromodulation Devices and Implantable Infusion Pumps Product Scope
1.2 Neuromodulation Devices and Implantable Infusion Pumps Segment by Type
1.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2016 & 2021 & 2027)
1.2.2 Spinal Cord Stimulation
1.2.3 Deep Brain Stimulation
1.2.4 Sacral Nerve Stimulation
1.2.5 Vagal Nerve Stimulation
1.2.6 Gastric Stimulation
1.2.7 Transcranial Magnetic Stimulation
1.2.8 Transcutaneous Electrical Stimulation
1.2.9 Other
1.3 Neuromodulation Devices and Implantable Infusion Pumps Segment by Application
1.3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Parkinson’s Disease
1.3.3 Epilepsy
1.3.4 Pain
1.3.5 Other
1.4 Neuromodulation Devices and Implantable Infusion Pumps Market Estimates and Forecasts (2016-2027)
1.4.1 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Neuromodulation Devices and Implantable Infusion Pumps Price Trends (2016-2027)
2 Neuromodulation Devices and Implantable Infusion Pumps Estimates and Forecasts by Region
2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Region (2016-2021)
2.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Region (2016-2021)
2.3 Global Neuromodulation Devices and Implantable Infusion Pumps Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Neuromodulation Devices and Implantable Infusion Pumps Estimates and Projections (2016-2027)
2.4.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Estimates and Projections (2016-2027)
2.4.3 China Neuromodulation Devices and Implantable Infusion Pumps Estimates and Projections (2016-2027)
2.4.4 Japan Neuromodulation Devices and Implantable Infusion Pumps Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Estimates and Projections (2016-2027)
2.4.6 India Neuromodulation Devices and Implantable Infusion Pumps Estimates and Projections (2016-2027)
3 Global Neuromodulation Devices and Implantable Infusion Pumps Competition Landscape by Players
3.1 Global Top Neuromodulation Devices and Implantable Infusion Pumps Players by Sales (2016-2021)
3.2 Global Top Neuromodulation Devices and Implantable Infusion Pumps Players by Revenue (2016-2021)
3.3 Global Neuromodulation Devices and Implantable Infusion Pumps Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Neuromodulation Devices and Implantable Infusion Pumps as of 2020)
3.4 Global Neuromodulation Devices and Implantable Infusion Pumps Average Price by Company (2016-2021)
3.5 Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size by Type
4.1 Global Neuromodulation Devices and Implantable Infusion Pumps Historic Market Review by Type (2016-2021)
4.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2016-2021)
4.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Type (2016-2021)
4.1.3 Global Neuromodulation Devices and Implantable Infusion Pumps Price by Type (2016-2021)
4.2 Global Neuromodulation Devices and Implantable Infusion Pumps Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Type (2022-2027)
4.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Forecast by Type (2022-2027)
4.2.3 Global Neuromodulation Devices and Implantable Infusion Pumps Price Forecast by Type (2022-2027)
5 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size by Application
5.1 Global Neuromodulation Devices and Implantable Infusion Pumps Historic Market Review by Application (2016-2021)
5.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2016-2021)
5.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Application (2016-2021)
5.1.3 Global Neuromodulation Devices and Implantable Infusion Pumps Price by Application (2016-2021)
5.2 Global Neuromodulation Devices and Implantable Infusion Pumps Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Application (2022-2027)
5.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Forecast by Application (2022-2027)
5.2.3 Global Neuromodulation Devices and Implantable Infusion Pumps Price Forecast by Application (2022-2027)
6 North America Neuromodulation Devices and Implantable Infusion Pumps Market Facts & Figures
6.1 North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Company
6.1.1 North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Company (2016-2021)
6.1.2 North America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Company (2016-2021)
6.2 North America Neuromodulation Devices and Implantable Infusion Pumps Sales Breakdown by Type
6.2.1 North America Neuromodulation Devices and Implantable Infusion Pumps Sales Breakdown by Type (2016-2021)
6.2.2 North America Neuromodulation Devices and Implantable Infusion Pumps Sales Breakdown by Type (2022-2027)
6.3 North America Neuromodulation Devices and Implantable Infusion Pumps Sales Breakdown by Application
6.3.1 North America Neuromodulation Devices and Implantable Infusion Pumps Sales Breakdown by Application (2016-2021)
6.3.2 North America Neuromodulation Devices and Implantable Infusion Pumps Sales Breakdown by Application (2022-2027)
7 Europe Neuromodulation Devices and Implantable Infusion Pumps Market Facts & Figures
7.1 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Company
7.1.1 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Company (2016-2021)
7.1.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue by Company (2016-2021)
7.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Breakdown by Type
7.2.1 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Breakdown by Type (2016-2021)
7.2.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Breakdown by Type (2022-2027)
7.3 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Breakdown by Application
7.3.1 Europe 133 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 133 Sales Breakdown by Application (2022-2027)
8 China Neuromodulation Devices and Implantable Infusion Pumps Market Facts & Figures
8.1 China Neuromodulation Devices and Implantable Infusion Pumps Sales by Company
8.1.1 China Neuromodulation Devices and Implantable Infusion Pumps Sales by Company (2016-2021)
8.1.2 China Neuromodulation Devices and Implantable Infusion Pumps Revenue by Company (2016-2021)
8.2 China Neuromodulation Devices and Implantable Infusion Pumps Sales Breakdown by Type
8.2.1 China Neuromodulation Devices and Implantable Infusion Pumps Sales Breakdown by Type (2016-2021)
8.2.2 China Neuromodulation Devices and Implantable Infusion Pumps Sales Breakdown by Type (2022-2027)
8.3 China Neuromodulation Devices and Implantable Infusion Pumps Sales Breakdown by Application
8.3.1 China 243 Sales Breakdown by Application (2016-2021)
8.3.2 China 243 Sales Breakdown by Application (2022-2027)
9 Japan Neuromodulation Devices and Implantable Infusion Pumps Market Facts & Figures
9.1 Japan Neuromodulation Devices and Implantable Infusion Pumps Sales by Company
9.1.1 Japan Neuromodulation Devices and Implantable Infusion Pumps Sales by Company (2016-2021)
9.1.2 Japan Neuromodulation Devices and Implantable Infusion Pumps Revenue by Company (2016-2021)
9.2 Japan Neuromodulation Devices and Implantable Infusion Pumps Sales Breakdown by Type
9.2.1 Japan Neuromodulation Devices and Implantable Infusion Pumps Sales Breakdown by Type (2016-2021)
9.2.2 Japan Neuromodulation Devices and Implantable Infusion Pumps Sales Breakdown by Type (2022-2027)
9.3 Japan Neuromodulation Devices and Implantable Infusion Pumps Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Market Facts & Figures
10.1 Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Sales by Company
10.1.1 Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Sales by Company (2016-2021)
10.1.2 Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Revenue by Company (2016-2021)
10.2 Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Sales Breakdown by Type
10.2.1 Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India Neuromodulation Devices and Implantable Infusion Pumps Market Facts & Figures
11.1 India Neuromodulation Devices and Implantable Infusion Pumps Sales by Company
11.1.1 India Neuromodulation Devices and Implantable Infusion Pumps Sales by Company (2016-2021)
11.1.2 India Neuromodulation Devices and Implantable Infusion Pumps Revenue by Company (2016-2021)
11.2 India Neuromodulation Devices and Implantable Infusion Pumps Sales Breakdown by Type
11.2.1 India Neuromodulation Devices and Implantable Infusion Pumps Sales Breakdown by Type (2016-2021)
11.2.2 India Neuromodulation Devices and Implantable Infusion Pumps Sales Breakdown by Type (2022-2027)
11.3 India Neuromodulation Devices and Implantable Infusion Pumps Sales Breakdown by Application
11.3.1 India Neuromodulation Devices and Implantable Infusion Pumps Sales Breakdown by Application (2016-2021)
11.3.2 India Neuromodulation Devices and Implantable Infusion Pumps Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Neuromodulation Devices and Implantable Infusion Pumps Business
12.1 Medtronic
12.1.1 Medtronic Corporation Information
12.1.2 Medtronic Business Overview
12.1.3 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Products Offered
12.1.5 Medtronic Recent Development
12.2 Boston Scientific Corporation
12.2.1 Boston Scientific Corporation Corporation Information
12.2.2 Boston Scientific Corporation Business Overview
12.2.3 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Products Offered
12.2.5 Boston Scientific Corporation Recent Development
12.3 Abbott
12.3.1 Abbott Corporation Information
12.3.2 Abbott Business Overview
12.3.3 Abbott Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Abbott Neuromodulation Devices and Implantable Infusion Pumps Products Offered
12.3.5 Abbott Recent Development
12.4 Synapse Biomedical
12.4.1 Synapse Biomedical Corporation Information
12.4.2 Synapse Biomedical Business Overview
12.4.3 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Products Offered
12.4.5 Synapse Biomedical Recent Development
12.5 Nevro Corporation
12.5.1 Nevro Corporation Corporation Information
12.5.2 Nevro Corporation Business Overview
12.5.3 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Products Offered
12.5.5 Nevro Corporation Recent Development
12.6 Neuropace
12.6.1 Neuropace Corporation Information
12.6.2 Neuropace Business Overview
12.6.3 Neuropace Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Neuropace Neuromodulation Devices and Implantable Infusion Pumps Products Offered
12.6.5 Neuropace Recent Development
12.7 Cyberonics
12.7.1 Cyberonics Corporation Information
12.7.2 Cyberonics Business Overview
12.7.3 Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Products Offered
12.7.5 Cyberonics Recent Development
12.8 Autonomic Technologies
12.8.1 Autonomic Technologies Corporation Information
12.8.2 Autonomic Technologies Business Overview
12.8.3 Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Products Offered
12.8.5 Autonomic Technologies Recent Development
12.9 Avery Biomedical
12.9.1 Avery Biomedical Corporation Information
12.9.2 Avery Biomedical Business Overview
12.9.3 Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Products Offered
12.9.5 Avery Biomedical Recent Development
12.10 Greatbatch Medical
12.10.1 Greatbatch Medical Corporation Information
12.10.2 Greatbatch Medical Business Overview
12.10.3 Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Products Offered
12.10.5 Greatbatch Medical Recent Development
13 Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Cost Analysis
13.1 Neuromodulation Devices and Implantable Infusion Pumps Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Neuromodulation Devices and Implantable Infusion Pumps
13.4 Neuromodulation Devices and Implantable Infusion Pumps Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Neuromodulation Devices and Implantable Infusion Pumps Distributors List
14.3 Neuromodulation Devices and Implantable Infusion Pumps Customers
15 Market Dynamics
15.1 Neuromodulation Devices and Implantable Infusion Pumps Market Trends
15.2 Neuromodulation Devices and Implantable Infusion Pumps Drivers
15.3 Neuromodulation Devices and Implantable Infusion Pumps Market Challenges
15.4 Neuromodulation Devices and Implantable Infusion Pumps Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Neuromodulation Devices and Implantable Infusion Pumps Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Neuromodulation Devices and Implantable Infusion Pumps Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Neuromodulation Devices and Implantable Infusion Pumps Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units) by Region (2016-2021)
Table 5. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Region (2016-2021)
Table 6. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Share by Region (2016-2021)
Table 8. Global Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Share Forecast by Region (2022-2027)
Table 12. Global Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Share by Company (2016-2021)
Table 14. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Share by Company (2016-2021)
Table 16. Global Neuromodulation Devices and Implantable Infusion Pumps by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neuromodulation Devices and Implantable Infusion Pumps as of 2020)
Table 17. Global Neuromodulation Devices and Implantable Infusion Pumps Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Sites and Area Served
Table 19. Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units) by Type (2016-2021)
Table 22. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Share by Type (2016-2021)
Table 23. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Neuromodulation Devices and Implantable Infusion Pumps Price (USD/Unit) by Type (2016-2021)
Table 25. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Share by Type (2022-2027)
Table 26. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Share by Type (2022-2027)
Table 28. Global Neuromodulation Devices and Implantable Infusion Pumps Price (USD/Unit) by Type (2022-2027)
Table 29. Global Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units) by Application (2016-2021)
Table 30. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Share by Application (2016-2021)
Table 31. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Neuromodulation Devices and Implantable Infusion Pumps Price (USD/Unit) by Application (2016-2021)
Table 33. Global Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units) by Application (2022-2027)
Table 34. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Share by Application (2022-2027)
Table 35. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Share by Application (2022-2027)
Table 37. Global Neuromodulation Devices and Implantable Infusion Pumps Price (USD/Unit) by Application (2022-2027)
Table 38. North America Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units) by Company (2016-2021)
Table 39. North America Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Company (2016-2021)
Table 40. North America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Company (2016-2021)
Table 42. North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2016-2021) & (K Units)
Table 43. North America Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2016-2021)
Table 44. North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2022-2027) & (K Units)
Table 45. North America Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2022-2027)
Table 46. North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2016-2021) & (K Units)
Table 47. North America Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2016-2021)
Table 48. North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2022-2027) & (K Units)
Table 49. North America Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2022-2027)
Table 50. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units) by Company (2016-2021)
Table 51. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Company (2016-2021)
Table 52. Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Company (2016-2021)
Table 54. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2016-2021) & (K Units)
Table 55. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2016-2021)
Table 56. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2022-2027) & (K Units)
Table 57. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2022-2027)
Table 58. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2016-2021) & (K Units)
Table 59. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2016-2021)
Table 60. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2022-2027) & (K Units)
Table 61. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2022-2027)
Table 62. China Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units) by Company (2016-2021)
Table 63. China Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Company (2016-2021)
Table 64. China Neuromodulation Devices and Implantable Infusion Pumps Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Company (2016-2021)
Table 66. China Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2016-2021) & (K Units)
Table 67. China Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2016-2021)
Table 68. China Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2022-2027) & (K Units)
Table 69. China Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2022-2027)
Table 70. China Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2016-2021) & (K Units)
Table 71. China Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2016-2021)
Table 72. China Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2022-2027) & (K Units)
Table 73. China Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2022-2027)
Table 74. Japan Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units) by Company (2016-2021)
Table 75. Japan Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Company (2016-2021)
Table 76. Japan Neuromodulation Devices and Implantable Infusion Pumps Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Company (2016-2021)
Table 78. Japan Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2016-2021) & (K Units)
Table 79. Japan Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2016-2021)
Table 80. Japan Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2022-2027) & (K Units)
Table 81. Japan Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2022-2027)
Table 82. Japan Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2016-2021) & (K Units)
Table 83. Japan Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2016-2021)
Table 84. Japan Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2022-2027) & (K Units)
Table 85. Japan Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2022-2027)
Table 98. India Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units) by Company (2016-2021)
Table 99. India Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Company (2016-2021)
Table 100. India Neuromodulation Devices and Implantable Infusion Pumps Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Company (2016-2021)
Table 102. India Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2016-2021) & (K Units)
Table 103. India Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2016-2021)
Table 104. India Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2022-2027) & (K Units)
Table 105. India Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2022-2027)
Table 106. India Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2016-2021) & (K Units)
Table 107. India Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2016-2021)
Table 108. India Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2022-2027) & (K Units)
Table 109. India Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2022-2027)
Table 110. Medtronic Corporation Information
Table 111. Medtronic Description and Business Overview
Table 112. Medtronic Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. Medtronic Neuromodulation Devices and Implantable Infusion Pumps Product
Table 114. Medtronic Recent Development
Table 115. Boston Scientific Corporation Corporation Information
Table 116. Boston Scientific Corporation Description and Business Overview
Table 117. Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Product
Table 119. Boston Scientific Corporation Recent Development
Table 120. Abbott Corporation Information
Table 121. Abbott Description and Business Overview
Table 122. Abbott Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Abbott Neuromodulation Devices and Implantable Infusion Pumps Product
Table 124. Abbott Recent Development
Table 125. Synapse Biomedical Corporation Information
Table 126. Synapse Biomedical Description and Business Overview
Table 127. Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product
Table 129. Synapse Biomedical Recent Development
Table 130. Nevro Corporation Corporation Information
Table 131. Nevro Corporation Description and Business Overview
Table 132. Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Product
Table 134. Nevro Corporation Recent Development
Table 135. Neuropace Corporation Information
Table 136. Neuropace Description and Business Overview
Table 137. Neuropace Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Neuropace Neuromodulation Devices and Implantable Infusion Pumps Product
Table 139. Neuropace Recent Development
Table 140. Cyberonics Corporation Information
Table 141. Cyberonics Description and Business Overview
Table 142. Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Product
Table 144. Cyberonics Recent Development
Table 145. Autonomic Technologies Corporation Information
Table 146. Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 147. Autonomic Technologies Description and Business Overview
Table 148. Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Product
Table 149. Autonomic Technologies Recent Development
Table 150. Avery Biomedical Corporation Information
Table 151. Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 152. Avery Biomedical Description and Business Overview
Table 153. Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product
Table 154. Avery Biomedical Recent Development
Table 155. Greatbatch Medical Corporation Information
Table 156. Greatbatch Medical Description and Business Overview
Table 157. Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 158. Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Product
Table 159. Greatbatch Medical Recent Development
Table 160. Production Base and Market Concentration Rate of Raw Material
Table 161. Key Suppliers of Raw Materials
Table 162. Neuromodulation Devices and Implantable Infusion Pumps Distributors List
Table 163. Neuromodulation Devices and Implantable Infusion Pumps Customers List
Table 164. Neuromodulation Devices and Implantable Infusion Pumps Market Trends
Table 165. Neuromodulation Devices and Implantable Infusion Pumps Market Drivers
Table 166. Neuromodulation Devices and Implantable Infusion Pumps Market Challenges
Table 167. Neuromodulation Devices and Implantable Infusion Pumps Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Neuromodulation Devices and Implantable Infusion Pumps Product Picture
Figure 2. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application in 2021 & 2027
Figure 6. Parkinson's Disease Examples
Figure 7. Epilepsy Examples
Figure 8. Pain Examples
Figure 9. Other Examples
Figure 10. Global Neuromodulation Devices and Implantable Infusion Pumps Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Growth Rate (2016-2027) & (US$ Million)
Figure 12. Global Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units) Growth Rate (2016-2027)
Figure 13. Global Neuromodulation Devices and Implantable Infusion Pumps Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 14. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Region: 2016 VS 2021
Figure 15. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Region: 2021 VS 2027
Figure 16. North America Neuromodulation Devices and Implantable Infusion Pumps Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. North America Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units) Growth Rate (2016-2027)
Figure 18. Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales (Million USD) Growth Rate (2016-2027)
Figure 20. China Neuromodulation Devices and Implantable Infusion Pumps Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. China Neuromodulation Devices and Implantable Infusion Pumps Sales (Million USD) and Growth Rate (2016-2027)
Figure 22. Japan Neuromodulation Devices and Implantable Infusion Pumps Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Japan Neuromodulation Devices and Implantable Infusion Pumps Sales (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Sales (Million USD) Growth Rate (2016-2027)
Figure 26. India Neuromodulation Devices and Implantable Infusion Pumps Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. India Neuromodulation Devices and Implantable Infusion Pumps Sales (Million USD) Growth Rate (2016-2027)
Figure 28. Global 5 Largest Neuromodulation Devices and Implantable Infusion Pumps Players Market Share by Revenue in Neuromodulation Devices and Implantable Infusion Pumps: 2016 & 2020
Figure 29. Neuromodulation Devices and Implantable Infusion Pumps Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 30. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Share by Type (2016-2021)
Figure 31. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate by Type in 2016 & 2020
Figure 32. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Share by Application (2016-2021)
Figure 33. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate by Application in 2016 & 2020
Figure 34. North America Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type in 2020
Figure 35. North America Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application in 2020
Figure 36. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type in 2020
Figure 37. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application in 2020
Figure 38. China Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type in 2020
Figure 39. China Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application in 2020
Figure 40. Japan Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type in 2020
Figure 41. Japan Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application in 2020
Figure 42. Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type in 2020
Figure 43. Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application in 2020
Figure 44. India Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type in 2020
Figure 45. India Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application in 2020
Figure 46. Key Raw Materials Price Trend
Figure 47. Manufacturing Cost Structure of Neuromodulation Devices and Implantable Infusion Pumps
Figure 48. Manufacturing Process Analysis of Neuromodulation Devices and Implantable Infusion Pumps
Figure 49. Neuromodulation Devices and Implantable Infusion Pumps Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed